KIORA PHARMACEUTICALS INC Earnings Per Share, Basic in USD/shares from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Kiora Pharmaceuticals Inc quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2018 to Q3 2025.
  • Kiora Pharmaceuticals Inc Earnings Per Share, Basic for the quarter ending September 30, 2025 was 0.01 USD/shares.
  • Kiora Pharmaceuticals Inc Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -3 USD/shares, a 36.9% increase year-over-year.
  • Kiora Pharmaceuticals Inc annual Earnings Per Share, Basic for 2024 was 0.93 USD/shares.
  • Kiora Pharmaceuticals Inc annual Earnings Per Share, Basic for 2023 was -24.3 USD/shares, a 30.7% decline from 2022.
  • Kiora Pharmaceuticals Inc annual Earnings Per Share, Basic for 2022 was -18.6 USD/shares, a 67.5% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

KIORA PHARMACEUTICALS INC Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3 $0.01 +$0.82 Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 -$4 -$1 $0 -1.89% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 -$4 -$1 -$5 -111% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 $0 -$2 +$6.40 +72.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-25
Q3 2024 -$5 -$1 +$6.49 +88.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 -$11 -$1 +$6.62 +92.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 -$18 $4.67 +$5.67 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 -$24 -$9 -$8 -722% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-25
Q3 2023 -$16 -$7 -$1 -21.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$15 -$7 -$7 -3872% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$8 -$1 +$10.30 +91.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$18 -$1 +$44.10 +97.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$62 -$6 +$5.31 +46.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$67 $0 +$0.16 +47.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$68 -$11 -$11 -4074% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$57 -$45 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$11 -$11 -2477% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $0 +$0.16 +37.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-08
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q1 2020 $0 -$1 -243% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-06
Q1 2019 $0.30 +$0.44 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08

KIORA PHARMACEUTICALS INC Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0.93 +$25.20 Jan 1, 2024 Dec 31, 2024 10-K 2025-03-25
2023 -$24 -$6 -30.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-25
2022 -$19 +$38.60 +67.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$57 -$56 -3734% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$1 Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.